Dr. Scott Anderson, Senior Principal Scientist, Research and Development
Scott Anderson
Senior Principal Scientist, Research and Development
Scott Anderson is a Senior R&D leader at Leica Biosystems, bringing over half a decade of expertise in leading research and operational teams. He holds a Ph.D. in Regenerative Medicine and a master’s degree in Immunobiology from the University of Newcastle.
Dr. Anderson is focused on new technologies, such as Artificial Intelligence and Recombinant manufacturing, to support advancements in Leica Biosystems assay development which translate to real life patient benefits.
Scott has co-authored multiple peer review articles and poster presentations and actively supports innovation across Leica Biosystems and its parent company, Danaher.
Immunohistochemistry (IHC) analysis has become a powerful and integral component in cancer research. It has been essential in biomarker discovery, with a growing demand for high-output methods that maximize data from limited tissue samples.
